Ferrate(VI) (FeVIO42, Fe(VI)) is an emerging oxidant/disinfectant to treat a wide range of contaminants and microbial pollutants in wastewater. This study describes the inactivation of murine ...

We analysed 16 635 norovirus sequences submitted between Jan 1, 2005, to Nov 17, 2016, of which 1372 (8·2%) sequences belonged to genotype GI, 15 256 (91·7%) to GII, and seven (<0·1%) to GIV.1. During ...

Gastroparesis (GP) refers to when the stomach takes longer than usual to empty its contents into the small intestine.

Norovirus GII.17 accounted for 75% of outbreaks in the US in the 2024-2025 season, outpacing outbreaks caused by the GII.4 norovirus, according to new data published in Emerging Infectious Diseases.

Vaxart will release Phase I trial data for its norovirus vaccine on June 11, 2025, followed by a management conference call. Vaxart, Inc., a biotechnology company focused on oral recombinant pill ...

In previous years, the U.S. saw norovirus outbreaks increase around December, which marked the start of the season of the virus. Between 2011 and 2024, GII.4 viruses caused less than 50% of US ...

Will norovirus surge early again this year? Here’s what scientists say. ... There’s no specific treatment for norovirus, but most people recover with a period of up to three days.

There’s no specific treatment for norovirus, but most people recover with a period of up to three days. “The norovirus can spread so quickly, but also, as we already talked about, norovirus ...

Increase in outbreaks of norovirus GII.17 over GII.4, United States, 2022–2025. Seasons are defined as September 1 of one year to August 31 of the next. The 2024–25 season is truncated to ...

How ‘Inflammaging’ Drives Cancer—and Points to New Treatments Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like ...

Adding niraparib to standard treatment can help slow cancer growth for people with mCSPC with HRR gene alterations. Significance Although a combination of androgen receptor pathway inhibitors has ...